Schizophrenia
Showing NaN - NaN of 153
Schizophrenia, Pediatric Trial in Hollywood, Atlanta (Lumateperone 42 mg, Lumateperone 28 mg)
Recruiting
- Schizophrenia
- Pediatric
- Lumateperone 42 mg
- Lumateperone 28 mg
-
Hollywood, Florida
- +1 more
Feb 17, 2022
Schizophrenia Trial in Worldwide (SEP363856, quetiapine XR)
Active, not recruiting
- Schizophrenia
- SEP363856
- quetiapine XR
-
Cerritos, California
- +45 more
Feb 16, 2022
Schizophrenia, Schizophreniform Disorder, Bipolar I Disorder Trial in Worldwide (ALKS 3831)
Active, not recruiting
- Schizophrenia
- +2 more
- ALKS 3831
-
Little Rock, Arkansas
- +85 more
Feb 10, 2022
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in United States (Integrated Treatment, Community Care)
Completed
- Schizophrenia
- +4 more
- Integrated Treatment
- Community Care
-
San Fernando, California
- +32 more
Oct 24, 2021
Schizophrenia, Alcohol Use Disorder Trial in Bulgaria, Poland, United States (Samidorphan + olanzapine (ALKS 3831), Placebo +
Completed
- Schizophrenia
- Alcohol Use Disorder
- Samidorphan + olanzapine (ALKS 3831)
- Placebo + olanzapine
-
Little Rock, Arkansas
- +70 more
Sep 14, 2021
Schizophrenia Trial in Bulgaria, Czechia, United States (Samidorphan (Low Dose), Samidorphan (Medium Dose), Samidorphan (High
Completed
- Schizophrenia
- Samidorphan (Low Dose)
- +4 more
-
Little Rock, Arkansas
- +60 more
Sep 10, 2021
Schizophrenia Trial in Worldwide (SEP-363856, Placebo - Cap)
Schizophrenia Trial in Worldwide (BI 425809 dose 1, BI 425809 dose 2, BI 425809 dose 3)
Completed
- Schizophrenia
- BI 425809 dose 1
- +4 more
-
Garden Grove, California
- +80 more
Feb 5, 2021
Schizophrenia Trial in United States (Any FDA approved antipsychotic agent, aripiprazole long acting injectable formulation)
Completed
- Schizophrenia
- Any FDA approved antipsychotic agent
- aripiprazole long acting injectable formulation
-
Tucson, Arizona
- +38 more
Nov 16, 2020